These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
233 related items for PubMed ID: 10091880
1. Drug susceptibility of Mycobacterium tuberculosis in a rural area of Bangladesh and its relevance to the national treatment regimens. Van Deun A, Aung KJ, Chowdhury S, Saha S, Pankaj A, Ashraf A, Rigouts L, Fissette K, Portaels F. Int J Tuberc Lung Dis; 1999 Feb; 3(2):143-8. PubMed ID: 10091880 [Abstract] [Full Text] [Related]
5. Development of acquired drug resistance in recurrent tuberculosis patients with various previous treatment outcomes. Yoshiyama T, Yanai H, Rhiengtong D, Palittapongarnpim P, Nampaisan O, Supawitkul S, Uthaivorawit W, Mori T. Int J Tuberc Lung Dis; 2004 Jan; 8(1):31-8. PubMed ID: 14974743 [Abstract] [Full Text] [Related]
6. Drug resistance of Mycobacterium tuberculosis in the Sunamganj District of Bangladesh. Storla DG, Rahim Z, Islam MA, Plettner S, Begum V, Myrvang B, Bjune G, Rønnild E, Dahle UR, Mannsåker T. Scand J Infect Dis; 2007 Jan; 39(2):142-5. PubMed ID: 17366031 [Abstract] [Full Text] [Related]
7. Rifampicin mono-resistant Mycobacterium tuberculosis in Bujumbura, Burundi: results of a drug resistance survey. Sanders M, Van Deun A, Ntakirutimana D, Masabo JP, Rukundo J, Rigouts L, Fissette K, Portaelst F. Int J Tuberc Lung Dis; 2006 Feb; 10(2):178-83. PubMed ID: 16499257 [Abstract] [Full Text] [Related]
10. Drug resistance pulmonary tuberculosis in the Eastern Province of Saudi Arabia. Al-Rubaish AM, Madania AA, Al-Muhanna FA. Saudi Med J; 2001 Sep; 22(9):776-9. PubMed ID: 11590451 [Abstract] [Full Text] [Related]
13. [Characteristics and treatment outcomes of INH-resistant or RFP-resistant tuberculosis]. Saito W, Nagayama N, Miyamoto M, Hara H, Suzuki J, Masuda K, Baba M, Tamura A, Nagai H, Akagawa S, Kawabe Y, Machida K, Kurashima A, Yotsumoto H. Kekkaku; 2003 Oct; 78(10):611-7. PubMed ID: 14621568 [Abstract] [Full Text] [Related]
15. Anti-tuberculosis drug resistance in Portugal. Antunes ML, Aleixo-Dias J, Antunes AF, Pereira MF, Raymundo E, Rodrigues MF. Int J Tuberc Lung Dis; 2000 Mar; 4(3):223-31. PubMed ID: 10751067 [Abstract] [Full Text] [Related]
16. Initial drug susceptibility profile of M. tuberculosis among patients under TB programme in South India. Santha T, Thomas A, Chandrasekaran V, Selvakumar N, Gopi PG, Subramani R, Rajeswari R, Rani B, Paramasivan CN, Perumal M, Wares F, Narayanan PR. Int J Tuberc Lung Dis; 2006 Jan; 10(1):52-7. PubMed ID: 16466037 [Abstract] [Full Text] [Related]
17. First-line anti-tuberculosis drug resistance patterns and trends at the national TB referral center in Iran--eight years of surveillance. Shamaei M, Marjani M, Chitsaz E, Kazempour M, Esmaeili M, Farnia P, Tabarsi P, Amiri MV, Mirsaeidi M, Mansouri D, Masjedi MR, Velayati AA. Int J Infect Dis; 2009 Sep; 13(5):e236-40. PubMed ID: 19285897 [Abstract] [Full Text] [Related]
18. Using treatment failure under effective directly observed short-course chemotherapy programs to identify patients with multidrug-resistant tuberculosis. Becerra MC, Freeman J, Bayona J, Shin SS, Kim JY, Furin JJ, Werner B, Sloutsky A, Timperi R, Wilson ME, Pagano M, Farmer PE. Int J Tuberc Lung Dis; 2000 Feb; 4(2):108-14. PubMed ID: 10694087 [Abstract] [Full Text] [Related]